Moreover, higher level of ROR1 is associated with more aggressiveness and poor prognosis in breast cancer and ovarian cancer, where ROR1 regulates expression of the genes involved in epithelial-mesenchymal transition (EMT)20, 21. This evidence concerns the gene ROR1 and breast cancer.